Access Statistics for Patricia M. Danzon

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality 0 2 2 391 0 2 7 1,193
Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets 0 1 2 72 1 3 14 243
Effects of Regulation on Drug Launch and Pricing in Interdependent Markets 0 0 0 245 0 0 2 798
Mandated Employment-Based Health Insurance: Incidence and Efficiency Effects 0 0 0 1 0 0 6 477
Mergers and Acquisitions in the Pharmaceutical and Biotech Industries 0 2 3 1,496 2 6 10 4,586
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement 0 0 0 96 2 2 3 198
Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? 0 0 0 4 0 0 1 12
Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy 0 0 1 96 0 0 1 344
Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances 0 0 0 539 0 1 4 1,976
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand 0 0 1 351 0 0 2 1,134
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 0 0 0 1 673
The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s 0 0 1 293 0 1 4 768
Vaccine Supply: Effects Of Regulation And Competition 0 0 0 22 2 2 3 156
Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 0 0 54 0 1 2 161
Total Working Papers 0 5 10 3,660 7 18 60 12,719


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
"Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market 0 0 0 39 0 0 1 188
A general model of the impact of absenteeism on employers and employees 0 0 1 142 0 0 3 691
A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth 0 0 0 17 0 0 1 61
Alternative Liability Regimes for Medical Injuries 0 0 0 1 0 0 0 16
At what price? 0 0 0 0 0 0 1 1
Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions." 0 0 0 0 0 0 0 294
Contingent Fees for Personal Injury Litigation 0 0 0 82 0 0 0 865
Cross-national price differences for pharmaceuticals: how large, and why? 0 1 2 320 0 1 4 729
Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues 0 1 5 14 0 2 7 43
Does Regulation Drive out Competition in Pharmaceutical Markets? 0 0 0 27 1 2 4 1,151
Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion 1 1 4 80 1 2 7 221
Health Care Reform 0 0 0 4 0 0 0 25
Health Insurance and the Growth in Pharmaceutical Expenditures 0 0 0 13 0 0 1 56
Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment 0 0 0 3 0 0 0 246
Hospital `profits': The effects of reimbursement policies 0 0 1 38 0 0 1 139
Liability and liability insurance for medical malpractice 0 0 1 58 0 1 4 180
Liability for Medical Malpractice 0 0 2 198 1 1 5 674
Medical negligence and the NHS: an economic analysis 0 0 1 1 0 0 1 161
Mergers and acquisitions in the pharmaceutical and biotech industries 0 1 1 326 1 3 15 1,061
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement 0 2 2 6 0 2 7 50
Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? 0 0 0 10 0 0 0 34
Price Cutting in Liability Insurance Markets 1 1 1 110 1 1 2 471
Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU 0 1 4 151 2 4 13 400
Price, Financial Quality, and Capital Flows in Insurance Markets 0 0 3 118 1 1 7 390
Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances 0 0 0 120 3 4 12 581
Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance 0 0 0 77 0 0 0 650
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 0 76 1 2 3 447
Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 0 0 2 86 0 3 7 303
Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 0 0 0 7 0 0 0 21
Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 0 0 0 6 0 0 3 48
Separation of the redistributive and allocative functions of government: A public choice perspective 0 0 0 68 0 0 0 463
The Economic Implications of Public Disability Insurance in the United States 0 0 0 46 0 0 0 205
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 53 0 0 0 183
The Frequency and Severity of Medical Malpractice Claims 0 0 0 7 0 0 0 596
The Political Economy of Workers' Compensation: Lessons for Product Liability 1 1 2 10 1 1 2 65
The Swedish patient compensation system: Myths and realities 0 0 1 94 1 1 5 225
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s 0 0 0 84 0 1 2 349
Tort Liability: A Minefield for Managed Care? 0 0 0 0 0 0 0 232
Tort Reform: The Case of Medical Malpractice 0 0 0 0 0 0 0 455
Vaccine Supply: Effects of Regulation and Competition 0 0 0 25 1 1 3 191
Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 0 1 21 0 1 7 137
Welfare effects of supplementary insurance: a comment 0 0 0 25 0 0 0 73
Worker's Compensation Rate Regulation: How Price Controls Increase Costs 0 0 0 1 0 0 1 428
Total Journal Articles 3 9 34 2,564 15 34 129 13,799


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison 0 0 0 7 0 0 4 59
The Life Cycle of Pharmaceuticals: A Cross-National Perspective 0 0 1 2 0 0 6 31
Trade and Price Differentials for Pharmaceuticals: Policy Options 0 0 3 17 0 1 13 88
Total Books 0 0 4 26 0 1 23 178


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Liability for medical malpractice 1 2 6 665 2 7 43 3,300
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 0 43 0 0 1 189
Regulation of the Biopharmaceutical Industry 0 0 2 16 0 0 2 23
Regulation of the Pharmaceutical-Biotechnology Industry 0 0 6 155 1 2 14 445
The Effects of Price Regulation on Productivity in Pharmaceuticals 0 0 0 21 0 0 0 69
Total Chapters 1 2 14 900 3 9 60 4,026


Statistics updated 2023-06-05